E. Yildirim Et Al. , "Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII," HIPPOKRATIA , vol.18, no.4, pp.319-327, 2014
Yildirim, E. Et Al. 2014. Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII. HIPPOKRATIA , vol.18, no.4 , 319-327.
Yildirim, E., Erol, K., & Birdane, A., (2014). Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII. HIPPOKRATIA , vol.18, no.4, 319-327.
Yildirim, ENGİN, K. Erol, And A. Birdane. "Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII," HIPPOKRATIA , vol.18, no.4, 319-327, 2014
Yildirim, ENGİN Et Al. "Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII." HIPPOKRATIA , vol.18, no.4, pp.319-327, 2014
Yildirim, E. Erol, K. And Birdane, A. (2014) . "Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII." HIPPOKRATIA , vol.18, no.4, pp.319-327.
@article{article, author={ENGİN YILDIRIM Et Al. }, title={Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII}, journal={HIPPOKRATIA}, year=2014, pages={319-327} }